Phosphocreatine-dependent Glutamate Uptake by Synaptic Vesicles
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“creatine has been reported to have anti-apoptotic, anti-excitotoxic, and anti-oxidative properties in vivo and in vitro [11,132,247]”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [247]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tabb, J. S., Kish, P. E., Van Dyke, R., & Ueda, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49549-5 · Cited by 182
Research works printed but not linked: 29
- Naito, 1983, J. Biol. Chem., 258, 696, 10.1016/S0021-9258(18)33100-4 · DOI · Paper page
- Hartinger, 1993, J. Biol. Chem., 268, 23122, 10.1016/S0021-9258(19)49435-0 · DOI · Paper page
- Naito, 1985, J. Neurochem., 44, 99, 10.1111/j.1471-4159.1985.tb07118.x · DOI · Paper page
- Maycox, 1988, J. Biol. Chem., 263, 15423, 10.1016/S0021-9258(19)37605-7 · DOI · Paper page
- Fykse, 1989, J. Neurochem., 52, 946, 10.1111/j.1471-4159.1989.tb02546.x · DOI · Paper page
- Lee, 1988, Proc. Natl. Acad. Sci. U. S. A., 85, 7265, 10.1073/pnas.85.19.7265 · DOI
- Wothe, 1990, Proc. Natl. Acad. Sci. U. S. A., 87, 5203, 10.1073/pnas.87.13.5203 · DOI · Paper page
- Fredholm, 1974, Acta Physiol. Scand., 91, 165, 10.1111/j.1748-1716.1974.tb05672.x · DOI
- Zemtsov, 1993, Am. J. Med. Sci., 305, 8, 10.1097/00000441-199301000-00002 · DOI
- Pettegrew, 1994, Neurobiol. Aging, 15, 117, 10.1016/0197-4580(94)90152-X · DOI · Paper page
- Bottomley, 1992, Radiology, 183, 695, 10.1148/radiology.183.3.1584923 · DOI · Paper page
- Michaelis, 1993, Radiology, 187, 219, 10.1148/radiology.187.1.8451417 · DOI · Paper page
- Kish, 1989, Methods Enzymol., 174, 9, 10.1016/0076-6879(89)74005-2 · DOI
- Lowry, 1951, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI · Paper page
- Klunk, 1994, Biol. Psychiatry, 35, 627
- Pettegrew, 1987, J. Neuropathol. Exp. Neurol., 46, 419, 10.1097/00005072-198707000-00002 · DOI
- Herder, 1990, Clin. Chim. Acta, 190, S4, 10.1016/0009-8981(90)90293-2 · doi:10.1016/0009-8981(90)90293-2
- Fykse, 1992, Neurosci. Lett., 135, 125, 10.1016/0304-3940(92)90151-V · DOI
- Carlson, 1989, J. Neurochem., 53, 1889, 10.1111/j.1471-4159.1989.tb09258.x · DOI
- Xu, 1995, J. Neurochem., 64, S49C
- Fan, 1994, Biochem. J., 299, 701, 10.1042/bj2990701 · doi:10.1042/bj2990701
- Fossel, 1987, Am. J. Physiol., 252, E124
- Wu, 1989, Biochim. Biophys. Acta, 997, 78, 10.1016/0167-4838(89)90137-4 · doi:10.1016/0167-4838(89)90137-4
- Hou, 1994, Biochim. Biophys. Acta, 1205, 83, 10.1016/0167-4838(94)90095-7 · doi:10.1016/0167-4838(94)90095-7
- Carpenter, 1983, Biochem. Biophys. Res. Commun., 111, 884, 10.1016/0006-291X(83)91382-7 · DOI
- Ouellet, 1992, Biochem. J., 284, 115, 10.1042/bj2840115 · DOI
- Rosenberg, 1989, Neurosci. Lett., 103, 162, 10.1016/0304-3940(89)90569-7 · DOI · Paper page
- Pettegrew, 1988, Arch. Neurol., 45, 1093, 10.1001/archneur.1988.00520340047010 · DOI · Paper page
- Pettegrew, 1988, J. Neuropathol. Exp. Neurol., 47, 235, 10.1097/00005072-198805000-00004 · DOI · Paper page
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 430
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., Jenkins, B. G., Ferrante, K. L., Thomas, M., Friedlich, A., Browne, S. E., Schilling, G., Borchelt, D. R., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0406 · Cited by 293
Bioenergetic approaches for neuroprotection in Parkinson's disease
Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169
Striatal Creatine and Glutamate/Glutamine in Attention-Deficit/Hyperactivity Disorder
Carrey, N. J., MacMaster, F. P., Gaudet, L., & Schmidt, M. H. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0008 · Cited by 117
“Creatine may indeed be neuro-protective glutamate uptake to the synaptic vesicles (Xu et al. 1996).”
Oral creatine supplementation and skeletal muscle metabolism in physical exercise
Mesa, J. L. M., Ruiz, J. R., Gonz??lez-Gross, M. M., Guti??rrez S??inz, ?., & Castillo Garz??n, M. J. (2002) · Sports Medicine · doi:10.2165/00007256-200232140-00003 · Cited by 103
Schlattner, U., Klaus, A., Ramirez Rios, S., Guzun, R., Kay, L., & Tokarska-Schlattner, M. (2016) · Amino Acids · doi:10.1007/s00726-016-2267-3 · Cited by 96
A review of creatine supplementation in age-related diseases: more than a supplement for athletes
Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82
“Rodent models often used for the study of PD are induced by toxins, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to mimic the pathogenesis and progression of the disease marked by dopaminergic neuron loss, mitochondrial dysfunction, and oxidative stress 53,54 .”
BackgroundDickinson, H., Ellery, S., Ireland, Z., LaRosa, D., Snow, R., & Walker, D. W. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-150 · Cited by 74
Kornblum, C., Schröder, R., Müller, K., Vorgerd, M., Eggers, J., Bogdanow, M., Papassotiropoulos, A., Fabian, K., Klockgether, T., & Zange, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00970.x · Cited by 65
“Potential neuroprotective and antioxidant effects of Cr are probably based on attenuation of neuronal excitotoxicity and enhancement of energy transduction (Xu et al., 1996; Tarnopolsky and Beal, 2001).”
BackgroundCreatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
(2012) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 21
Metadata
- Authors
- Xu, C. J., Klunk, W. E., Kanfer, J. N., Xiong, Q., Miller, G., & Pettegrew, J. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-06
- Volume
- 271
- Issue
- 23
- Pages
- 13435-13440
- ISSN
- 0021-9258
- Cited by
- 78
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8902 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.